Antoinette Burger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Antoinette Burger has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Joseph Stein
University of Cape Town
4 shared publications - Fleur Margaret Howells
University of Cape Town
2 shared publications - Susan Janse van Rensburg
Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2 shared publications A Bagadia
Department of Radiology, Stellenbosch University, Cape Town, South Africa
1 shared publicationA Peeters
Anatomical Pathology, NHLS and Stellenbosch University, Cape Town, South Africa
1 shared publication- A. M.E. Du Plessis
Department of Psychiatry, University of Pretoria; Weskoppies Hospital, Pretoria, South Africa
1 shared publication
Latest Publications
- Open Access
Subcortical volumes, frontal cortical thickness, and pro-inflammatory cytokines in schizophrenia versus methamphetamine-induced psychosis
Background Clinical features of schizophrenia and methamphetamine-induced psychosis (MAP) have significant overlap. Schizophrenia is associated with alterations in subcortical volumes, cortical thickness and pro-inflammatory cytokines that may correlate with clinical features. However, analogous work on MAP is lacking. This study compared subcortical volumes, cortical thickness and pro-inflammatory cytokines in individuals with schizophrenia, MAP, and healthy controls. It also assessed associations of neuroimaging measures and cytokine levels with each other, with illness duration and symptom severity in schizophrenia and MAP, and with duration of substance use in MAP. Methods Participants included 36 individuals with schizophrenia, 27 with MAP, and 32 healthy controls matched for age and sex. Diagnosis was determined using the Structured Clinical Interview for Axis I Disorders and symptom severity was assessed using the Positive and Negative Syndrome Scale. Structural T1-weighted images were acquired using a 3 Tesla magnetic resonance imaging scanner. Serum peripheral cytokine concentrations levels were measured using a multiplex bead array. Analysis of covariance was used to compare measures across groups. Results Individuals with schizophrenia and with MAP had decreased left amygdala volumes and frontal cortical thickness compared to healthy controls. Individuals with schizophrenia had increased volumes in bilateral caudate, putamen, and nucleus accumbens compared to healthy controls, and increased right globus pallidus and NAcc volumes compared to MAP. Individuals with MAP had increased right orbitofrontal cortical thickness compared to healthy controls. Decreased left amygdala volumes and frontal cortical thickness were significantly associated with longer illness duration in schizophrenia, and with longer duration of methamphetamine use in MAP. There was no significant difference across groups in cytokine levels, and no significant associations of cytokine levels with neuroimaging or clinical measures. Conclusion This study found overlaps and differences in the neurobiology of schizophrenia and MAP, a finding that is consistent with previous research. Further studies with larger sample sizes and more robust measures are needed to understand immune mechanisms underlying these conditions.
Open AccessSubcortical volumes, frontal cortical thickness, and pro-inflammatory cytokines in schizophrenia versus methamphetamine-induced psychosis
Background Clinical features of schizophrenia and methamphetamine-induced psychosis (MAP) have significant overlap. Schizophrenia is associated with alterations in subcortical volumes, cortical thickness and pro-inflammatory cytokines that may correlate with clinical features. However, analogous work on MAP is lacking. This study compared subcortical volumes, cortical thickness and pro-inflammatory cytokines in individuals with schizophrenia, MAP, and healthy controls. It also assessed associations of neuroimaging measures and cytokine levels with each other, with illness duration and symptom severity in schizophrenia and MAP, and with duration of substance use in MAP. Methods Participants included 36 individuals with schizophrenia, 27 with MAP, and 32 healthy controls matched for age and sex. Diagnosis was determined using the Structured Clinical Interview for Axis I Disorders and symptom severity was assessed using the Positive and Negative Syndrome Scale. Structural T1-weighted images were acquired using a 3 Tesla magnetic resonance imaging scanner. Serum peripheral cytokine concentrations levels were measured using a multiplex bead array. Analysis of covariance was used to compare measures across groups. Results Individuals with schizophrenia and with MAP had decreased left amygdala volumes and frontal cortical thickness compared to healthy controls. Individuals with schizophrenia had increased volumes in bilateral caudate, putamen, and nucleus accumbens compared to healthy controls, and increased right globus pallidus and NAcc volumes compared to MAP. Individuals with MAP had increased right orbitofrontal cortical thickness compared to healthy controls. Decreased left amygdala volumes and frontal cortical thickness were significantly associated with longer illness duration in schizophrenia, and with longer duration of methamphetamine use in MAP. There was no significant difference across groups in cytokine levels, and no significant associations of cytokine levels with neuroimaging or clinical measures. Conclusion This study found overlaps and differences in the neurobiology of schizophrenia and MAP, a finding that is consistent with previous research. Further studies with larger sample sizes and more robust measures are needed to understand immune mechanisms underlying these conditions.
- Open Access
- 27 February 2023
- Published by Wiley
Comparison of schizophrenia and methamphetamine-induced psychosis: a proton magnetic resonance spectroscopy and cytokine study.
Background: There is similarity in schizophrenia and methamphetamine-induced psychosis neurobiology. Few studies have directly compared neurometabolites in thalamo-cortical circuitry across these disorders or assessed the relationship with peripheral cytokines. This study compared neurometabolites and neuronal integrity in thalamo-cortical circuitry, and investigated associations with peripheral cytokine levels in both disorders. Methods: Ninety-five participants were recruited – 36 with schizophrenia, 27 with methamphetamine-induced psychosis, and 32 healthy controls. All participants underwent a magnetic resonance imaging scan, which included magnetic resonance spectroscopy. Glutamatergic and neuroinflammatory neurometabolites were examined. Serum cytokine concentrations included Interleukin 1-beta, Interleukin-8, Interleukin-10, Tumor Necrosis Factor alpha and Interferon gamma. Parametric data were analyzed with one-way analysis of variance and non-parametric data were analyzed with Kruskal Wallis tests. Associations were determined using Spearman’s rank-order coefficient. Results: The methamphetamine-induced psychosis group had lower n-acetyl aspartate with n-acetyl-aspartyl glutamate in left dorsolateral prefrontal cortex and left frontal white matter, compared to controls. In schizophrenia, positive associations were found between glutamate and n-acetyl aspartate and n-acetyl aspartate with n-acetyl-aspartyl glutamate in the anterior cingulate cortex. In the methamphetamine-induced psychosis group, positive relationships were found between myo-inositol in the left thalamus and bilateral anterior cingulate cortex. Conclusion: In schizophrenia, there is suggestion of dysfunction in neuronal tissues in the glutamate-glutamine cycle within the thalamo-cortical circuit. In methamphetamine-induced psychosis, there is evidence of compromised neuronal integrity associated with chronic disease progression, and suggestion of aberrant neuroinflammatory regulation in the thalamus-ACC circuit. This study highlights similarities and differences in the psychobiology of the two disorders
- 27 February 2023
- Published by Wiley
Open AccessComparison of schizophrenia and methamphetamine-induced psychosis: a proton magnetic resonance spectroscopy and cytokine study.
Background: There is similarity in schizophrenia and methamphetamine-induced psychosis neurobiology. Few studies have directly compared neurometabolites in thalamo-cortical circuitry across these disorders or assessed the relationship with peripheral cytokines. This study compared neurometabolites and neuronal integrity in thalamo-cortical circuitry, and investigated associations with peripheral cytokine levels in both disorders. Methods: Ninety-five participants were recruited – 36 with schizophrenia, 27 with methamphetamine-induced psychosis, and 32 healthy controls. All participants underwent a magnetic resonance imaging scan, which included magnetic resonance spectroscopy. Glutamatergic and neuroinflammatory neurometabolites were examined. Serum cytokine concentrations included Interleukin 1-beta, Interleukin-8, Interleukin-10, Tumor Necrosis Factor alpha and Interferon gamma. Parametric data were analyzed with one-way analysis of variance and non-parametric data were analyzed with Kruskal Wallis tests. Associations were determined using Spearman’s rank-order coefficient. Results: The methamphetamine-induced psychosis group had lower n-acetyl aspartate with n-acetyl-aspartyl glutamate in left dorsolateral prefrontal cortex and left frontal white matter, compared to controls. In schizophrenia, positive associations were found between glutamate and n-acetyl aspartate and n-acetyl aspartate with n-acetyl-aspartyl glutamate in the anterior cingulate cortex. In the methamphetamine-induced psychosis group, positive relationships were found between myo-inositol in the left thalamus and bilateral anterior cingulate cortex. Conclusion: In schizophrenia, there is suggestion of dysfunction in neuronal tissues in the glutamate-glutamine cycle within the thalamo-cortical circuit. In methamphetamine-induced psychosis, there is evidence of compromised neuronal integrity associated with chronic disease progression, and suggestion of aberrant neuroinflammatory regulation in the thalamus-ACC circuit. This study highlights similarities and differences in the psychobiology of the two disorders
- 4 October 2019
- Published by Wiley in European Journal of Neuroscience
- Vol. 51 (4) , 984-990
The relationship between measurement of in vivo brain glutamate and markers of iron metabolism: A proton magnetic resonance spectroscopy study in healthy adults
Fundamental human studies which address associations between glutamate and iron metabolism are needed. Basic research reports associations between glutamate and iron metabolism. Human studies report sex differences in iron metabolism and glutamate concentrations, which suggest that these relationships may differ by sex. We hypothesised associations would be apparent between in vivo glutamate and peripheral markers of iron metabolism, and these associations would differ by sex. To test this, we recruited 40 healthy adults (20 men, 20 women) and measured (a) standard clinical biomarker concentrations for iron metabolism and (b) an in vivo proxy for glutamate concentration, glutamate with glutamine in relation to total creatine containing metabolites using proton magnetic resonance spectroscopy studies with a two‐dimensional chemical shift imaging slice, with voxels located in bilateral dorsolateral prefrontal cortices, anterior cingulate cortices and frontal white matter. Only the female group reported significant associations between peripheral markers of iron metabolism and Glx:tCr concentration: (a) right dorsolateral prefrontal cortex Glx:tCr associated positively with serum transferrin (r = .60, p = .006) and negatively with transferrin saturation (r = −.62, p = .004) and (b) right frontal white matter Glx:tCr associated negatively with iron concentration (r = −.59, p = .008) and transferrin saturation (r = −.65, p = .002). Our results support associations between iron metabolism and our proxy for in vivo glutamate concentration (Glx:tCr). These associations were limited to women, suggesting a stronger regulatory control between iron and glutamate metabolism. These associations support additional fundamental research into the molecular mechanisms of this regulatory control.
- 4 October 2019
- Published by Wiley in European Journal of Neuroscience
- Vol. 51 (4) , 984-990
The relationship between measurement of in vivo brain glutamate and markers of iron metabolism: A proton magnetic resonance spectroscopy study in healthy adults
Fundamental human studies which address associations between glutamate and iron metabolism are needed. Basic research reports associations between glutamate and iron metabolism. Human studies report sex differences in iron metabolism and glutamate concentrations, which suggest that these relationships may differ by sex. We hypothesised associations would be apparent between in vivo glutamate and peripheral markers of iron metabolism, and these associations would differ by sex. To test this, we recruited 40 healthy adults (20 men, 20 women) and measured (a) standard clinical biomarker concentrations for iron metabolism and (b) an in vivo proxy for glutamate concentration, glutamate with glutamine in relation to total creatine containing metabolites using proton magnetic resonance spectroscopy studies with a two‐dimensional chemical shift imaging slice, with voxels located in bilateral dorsolateral prefrontal cortices, anterior cingulate cortices and frontal white matter. Only the female group reported significant associations between peripheral markers of iron metabolism and Glx:tCr concentration: (a) right dorsolateral prefrontal cortex Glx:tCr associated positively with serum transferrin (r = .60, p = .006) and negatively with transferrin saturation (r = −.62, p = .004) and (b) right frontal white matter Glx:tCr associated negatively with iron concentration (r = −.59, p = .008) and transferrin saturation (r = −.65, p = .002). Our results support associations between iron metabolism and our proxy for in vivo glutamate concentration (Glx:tCr). These associations were limited to women, suggesting a stronger regulatory control between iron and glutamate metabolism. These associations support additional fundamental research into the molecular mechanisms of this regulatory control.
- Open Access
- 16 September 2015
- Published by AOSIS in South African Journal of Psychiatry
- Vol. 21 (3) , 108
Biological Psychiatry Congress 2015
List of Abstract Titles and authors: 1. Psychosis: A matter of mental effort? M Borg, Y Y van der Zee, J H Hsieh, H Temmingh, D J Stein, F M Howells 2.In search of an affordable, effective post-discharge intervention: A randomised control trial assessing the influence of a telephone-based intervention on readmissions for patients with severe mental illness in a developing country U A Botha, L Koen, M Mazinu, E Jordaan, D J H Niehaus 3. The effect of early abstinence from long-term methamphetamine use on brain metabolism using 1H-magnetic resonance spectro-scopy (1H-MRS) A Burger, S Brooks, D J Stein, F M Howells 4. The effect of in utero exposure to methamphetamine on brain metabolism in childhood using 1H-magnetic resonance spectroscopy (1H-MRS) A Burger, A Roos, M Kwiatkowski, D J Stein, K A Donald, F M Howells 5. A prospective study of clinical, biological and functional aspects of outcome in first-episode psychosis: The EONKCS Study B Chiliza, L Asmal, R Emsley 6. Stimulants as cognitive enhancers - perceptions v. evidence in a very real world H M Clark 7. Pharmacogenomics in antipsychotic drugs Ilse du Plessis 8. Serotonin in anxiety disorders and beyond Ilse du Plessis 9. HIV infection results in ventral-striatal reward system hypo-activation during cue processing S du Plessis, M Vink, J A Joska, E Koutsilieri, A Bagadia, D J Stein, R Emsley 10. Disease progression in schizophrenia: Is the illness or the treatment to blame? R Emsley, M J Sian 11. Serotonin transporter variants play a role in anxiety sensitivity in South African adolescents S M J Hemmings, L I Martin, L van der Merwe, R Benecke, K Domschke, S Seedat 12. Iron deficiency in two children diagnosed with multiple sclerosis: Report on whole exom sequencing S Janse van Rensburg, R van Toorn, J F Schoeman, A Peeters, L R Fisher, K Moremi, M J Kotze 13. Benzodiazepines: Practical pharmacokinetics P Joubert 14. What to consider when prescribing psychotropic medications G Lippi 15. Current prescribing practices for obsessive-compulsive disorder in South Africa: Controversies and consensus C Lochner, L Taljaard, D J Stein 16. Correlates of emotional and behavioural problems in children with preinatally acquired HIV in Cape Town, South Africa K-A Louw, N Phillips, JIpser, J Hoare 17. The role of non-coding RNAs in fear extinction S Malan-Muller, L Fairbairn, W M U Daniels, M J S Dashti, E J Oakleley, M Altorfer, J Harvey, S Seedat, J Gamieldien, S M J Hemmings 18. An analysis of the management og HIV-mental illness comorbidity at the psychiatric unit of the Dr George Mukhari Academic Hospital M L Maodi, S T Rataemane, T Kyaw 19. The identification of novel genes in anxiety disorders: A gene X environment correlation and interaction study N W McGregor, J Dimatelis, S M J Hemmings, C J Kinnear, D J Stein, V Russel, C Lochner 20. Collaborations between conventional medicine and traditional healers: Obstacles and possibilities G Nortje, S Seedat, O Gureje 21. Thought disorder and form perception: Relationships with symptoms and cognitive function in first-episode schizophrenia M R Olivier, R Emsley 22. Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response E Ovenden, B Drogemoller, L van der Merwe, R Emsley, L Warnich 23. The moral and bioethical determinants of "futility" in psychiatry W P Pienaar 24. Single voxel proton magnetic resonance spectroscopy (1H-MRS) and volumetry of the amylgdala in social anxiety disorder in the context of early developmental trauma D Rosenstein, A T Hess, J Zwart, F Ahmed-Leitao, E Meintjies, S Seedat 25. Schizoaffective disorder in an acute psychiatric unit: Profile of users and agreement with Operational Criteria (OPCRIT) R R Singh, U Subramaney 26. The right to privacy and confidentiality: The ethics of expert diagnosis in the public media and the Oscar Pistorius trial C Smith 27. A birth cohort study in South Africa: A psychiatric perspective D J Stein 28. 'Womb Raiders': Women referred for observation in terms of the Criminal Procedures Act (CPA) charged with fetal abduction and murder U Subramaney 29. Psycho-pharmacology of sleep wake disorders: An update R Sykes 30. Refugee post-settlement in South Africa: Role of adjustment challenges and family in mental health outcomes L Thela, A Tomita, V Maharaj, M Mhlongo, K Jonathan 31. Dstinguishing ADHD symptoms in psychotic disorders: A new insight in the adult ADHD questionnaire Y van der Zee, M Borg, J H Hsieh, H Temmingh, D J Stein, F M Howells 32. Oscar Pistorius ethical dilemmas in a trial by media: Does this include psychiatric evaluation by media? M Vorster 33. Genetic investigation of apetite aggression in South African former young offenders: The involvement of serotonin transporter gene K Xulu, J Somer, M Hinsberger, R Weierstall, T Elbert, S Seedat, S Hemmings 34. Effects of HIV and childhood trauma on brain morphemtry and neurocognitive function G Spies, F Ahmed-Leitao, C Fennema-Notestine, M Cherner, S Seedat 35. Measuring intentional behaviour normative data of a newly developed motor task battery S Bakelaar, J Blampain, S Seedat, J van Hoof, Y Delevoye-Turrel 36. Resilience in social anxiety disorder and post-traumatic stress disorder in the context of childhood trauma M Bship, S Bakelaar, D Rosenstein, S Seedat 37. The ethical dilemma of seclusion practices in psychiatry G Chiba, U Subramaney 38. Physical activity and neurological soft signs in patients with schizophrenia O Esan, C Osunbote, I Oladele, S Fakunle, C Ehindero 39. A retrospective study of completed suicides in the Nelson Mandela Bay Metropolitan Area from 2008 to 2013 - preliminary results C Grobler, J Strumpher, R Jacobs 40. Serotonin transporter variants play a role in anxiety sensitivity in South African adolescents S M J Hemmings, L I Martin, L van der Merwe, R Benecke, K Domschke, S Seedat 41. Investigation of variants within antipsychotic candidate pharmacogenes associated with treatment outcome F Higgins, B Drogmoller, G Wright, L van der Merwe, N McGregor, B Chiliza, L Asmal, L Koen, D Niehaus, R Emsley, L Warnich 42. Effects of diet, smoking and alcohol consumption on disability (EDSS) in people diagnosed with multiple sclerosis S Janse van Rensburg, W Davis, D Geiger, F J Cronje, L Whati, M Kidd, M J Kotze 43. The clinical utility of neuroimaging in an acute adolescnet psychiatric inpatient population Z Khan, A Lachman, J Harvey 44. Relationships between childhood trauma (CT) and premorbid adjustment (PA) in a highly traumatised sample of patients with first-episode schizophrenia (FES) S Kilian, J Burns, S Seedat, L Asmal, B Chiliza, S du Plessis, R Olivier, R Emsley 45. Functional and cognitive outcomes using an mTOR inhibitor in an adolescent with TSC A Lachman, C van der Merwe, P Boyes, P de Vries 46. Perceptions about adolescent body image and eating behaviour K Laxton, A B R Janse van Rensburg 47. Clinical relevance of FTO rs9939609 as a determinant of cardio-metabolic risk in South African patients with major depressive disorder H K Luckhoff, M J Kotze 48. Childhood abuse and neglect as predictors of deficits in verbal auditory memory in non-clinical adolescents with low anxiety proneness L Martin, K Martin, S Seedat 49. The changes of pro-inflammatory cytokines in a prenatally stressed febrile seizure animal model and whether Rhus chirindensis may attenuate these changes A Mohamed, M V Mabandla, L Qulu 50. Influence of TMPRSS6 A736v and HFE C282y on serum iron parameters and age of onset in patients with multiple sclerosis K E Moremi, M J Kotze, H K Luckhoff, L R Fisher, M Kidd, R van Toorn, S Janse van Rensburg 51. Polypharmacy in pregnant women with serious mental illness E Thomas, E du Toit, L Koen, D Niehaus 52. Infant attachment and maternal depression as predictors of neurodevelopmental and behavioural outcomes at follow-up J Nothling, B Laughton, S Seedat 53. Differences in abuse, neglect and exposure to community violence in adolescents with and without PTSD J Nothling, S Suliman, L Martin, C Simmons, S Seedat 54. Assessment of oxidative stress markers in children with autistic spectrum disorders in Lagos, Nigeria Y Oshodi, O Ojewunmi, T A Oshodi, T Ijarogbe, O F Aina, J Okpuzor, O C F E A Lesi 55. Change in diagnosis and management of 'gender identity disorder' in pre-adolescent children S Pickstone-Taylor 56. Brain network connectivity in women exposed to intimate partner violence A Roos, J-P Fouche, B Vythilingum, D J Stein 57. Prolonged exposure treatment for PTSD in a Third-World, task-shifting, community-based environment J Rossouw, E Yadin, I Mbanga, T Jacobs, W Rossouw, D Alexander, S Seedat 58. Contrasting effects of early0life stress on mitochondrial energy-related proteins in striatum and hippocampus of a rat model of attention-deficit/ hyperactivity disorder V Russell, J Dimatelis, J Womersley, T-L Sterley 59. Attention-deficit hyperactivity disorder in adults: A South African perspective R Schoeman, M de Klerk, M Kidd 60. Cognitive function in women with HIV infection and early-life stress G Spies, C Fennema-Notestine, M Cherner, S Seedat 61. Changes in functional connectivity networks in bipolar disorder patients after mindfulness-based cognitic therapy J A Starke, C F Beckmann, N Horn 62. Post-traumatic stress disorder, overweight and obesity: A systematic review and meta-analysis S Suliman, L Anthonissen, J Carr, S du Plessis, R Emsley, S M J Hemmings, C Lochner, N McGregor L van den Heuvel, S Seedat 63. The brain and behaviour in a third-trimester equivalent animal model of fetal alcohol spectrum disorders P C Swart, C B Currin, J J Dimatelis, V A Russell 64. Irritability Assessment Model (IAM) to monitor irritability in child and adolescent psychiatric disorders. D van der Westhuizen 65. Outcome of parent-adolescent training in chilhood victimisation: Adaptive functioning, psychosocial and physiological variables D van der Westhuizen 66. The effect of ketamine in the Wistar-Kyoto and Sprague Dawley rat models of depression P J van Zyl, J J Dimatelis, V A Russell 67. Investigating COMT variants in anxiety sensitivity in South African adolescents L J Zass, L Martin, S Seedat, S M J Hemmings
- 16 September 2015
- Published by AOSIS in South African Journal of Psychiatry
- Vol. 21 (3) , 108
Open AccessBiological Psychiatry Congress 2015
List of Abstract Titles and authors: 1. Psychosis: A matter of mental effort? M Borg, Y Y van der Zee, J H Hsieh, H Temmingh, D J Stein, F M Howells 2.In search of an affordable, effective post-discharge intervention: A randomised control trial assessing the influence of a telephone-based intervention on readmissions for patients with severe mental illness in a developing country U A Botha, L Koen, M Mazinu, E Jordaan, D J H Niehaus 3. The effect of early abstinence from long-term methamphetamine use on brain metabolism using 1H-magnetic resonance spectro-scopy (1H-MRS) A Burger, S Brooks, D J Stein, F M Howells 4. The effect of in utero exposure to methamphetamine on brain metabolism in childhood using 1H-magnetic resonance spectroscopy (1H-MRS) A Burger, A Roos, M Kwiatkowski, D J Stein, K A Donald, F M Howells 5. A prospective study of clinical, biological and functional aspects of outcome in first-episode psychosis: The EONKCS Study B Chiliza, L Asmal, R Emsley 6. Stimulants as cognitive enhancers - perceptions v. evidence in a very real world H M Clark 7. Pharmacogenomics in antipsychotic drugs Ilse du Plessis 8. Serotonin in anxiety disorders and beyond Ilse du Plessis 9. HIV infection results in ventral-striatal reward system hypo-activation during cue processing S du Plessis, M Vink, J A Joska, E Koutsilieri, A Bagadia, D J Stein, R Emsley 10. Disease progression in schizophrenia: Is the illness or the treatment to blame? R Emsley, M J Sian 11. Serotonin transporter variants play a role in anxiety sensitivity in South African adolescents S M J Hemmings, L I Martin, L van der Merwe, R Benecke, K Domschke, S Seedat 12. Iron deficiency in two children diagnosed with multiple sclerosis: Report on whole exom sequencing S Janse van Rensburg, R van Toorn, J F Schoeman, A Peeters, L R Fisher, K Moremi, M J Kotze 13. Benzodiazepines: Practical pharmacokinetics P Joubert 14. What to consider when prescribing psychotropic medications G Lippi 15. Current prescribing practices for obsessive-compulsive disorder in South Africa: Controversies and consensus C Lochner, L Taljaard, D J Stein 16. Correlates of emotional and behavioural problems in children with preinatally acquired HIV in Cape Town, South Africa K-A Louw, N Phillips, JIpser, J Hoare 17. The role of non-coding RNAs in fear extinction S Malan-Muller, L Fairbairn, W M U Daniels, M J S Dashti, E J Oakleley, M Altorfer, J Harvey, S Seedat, J Gamieldien, S M J Hemmings 18. An analysis of the management og HIV-mental illness comorbidity at the psychiatric unit of the Dr George Mukhari Academic Hospital M L Maodi, S T Rataemane, T Kyaw 19. The identification of novel genes in anxiety disorders: A gene X environment correlation and interaction study N W McGregor, J Dimatelis, S M J Hemmings, C J Kinnear, D J Stein, V Russel, C Lochner 20. Collaborations between conventional medicine and traditional healers: Obstacles and possibilities G Nortje, S Seedat, O Gureje 21. Thought disorder and form perception: Relationships with symptoms and cognitive function in first-episode schizophrenia M R Olivier, R Emsley 22. Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response E Ovenden, B Drogemoller, L van der Merwe, R Emsley, L Warnich 23. The moral and bioethical determinants of "futility" in psychiatry W P Pienaar 24. Single voxel proton magnetic resonance spectroscopy (1H-MRS) and volumetry of the amylgdala in social anxiety disorder in the context of early developmental trauma D Rosenstein, A T Hess, J Zwart, F Ahmed-Leitao, E Meintjies, S Seedat 25. Schizoaffective disorder in an acute psychiatric unit: Profile of users and agreement with Operational Criteria (OPCRIT) R R Singh, U Subramaney 26. The right to privacy and confidentiality: The ethics of expert diagnosis in the public media and the Oscar Pistorius trial C Smith 27. A birth cohort study in South Africa: A psychiatric perspective D J Stein 28. 'Womb Raiders': Women referred for observation in terms of the Criminal Procedures Act (CPA) charged with fetal abduction and murder U Subramaney 29. Psycho-pharmacology of sleep wake disorders: An update R Sykes 30. Refugee post-settlement in South Africa: Role of adjustment challenges and family in mental health outcomes L Thela, A Tomita, V Maharaj, M Mhlongo, K Jonathan 31. Dstinguishing ADHD symptoms in psychotic disorders: A new insight in the adult ADHD questionnaire Y van der Zee, M Borg, J H Hsieh, H Temmingh, D J Stein, F M Howells 32. Oscar Pistorius ethical dilemmas in a trial by media: Does this include psychiatric evaluation by media? M Vorster 33. Genetic investigation of apetite aggression in South African former young offenders: The involvement of serotonin transporter gene K Xulu, J Somer, M Hinsberger, R Weierstall, T Elbert, S Seedat, S Hemmings 34. Effects of HIV and childhood trauma on brain morphemtry and neurocognitive function G Spies, F Ahmed-Leitao, C Fennema-Notestine, M Cherner, S Seedat 35. Measuring intentional behaviour normative data of a newly developed motor task battery S Bakelaar, J Blampain, S Seedat, J van Hoof, Y Delevoye-Turrel 36. Resilience in social anxiety disorder and post-traumatic stress disorder in the context of childhood trauma M Bship, S Bakelaar, D Rosenstein, S Seedat 37. The ethical dilemma of seclusion practices in psychiatry G Chiba, U Subramaney 38. Physical activity and neurological soft signs in patients with schizophrenia O Esan, C Osunbote, I Oladele, S Fakunle, C Ehindero 39. A retrospective study of completed suicides in the Nelson Mandela Bay Metropolitan Area from 2008 to 2013 - preliminary results C Grobler, J Strumpher, R Jacobs 40. Serotonin transporter variants play a role in anxiety sensitivity in South African adolescents S M J Hemmings, L I Martin, L van der Merwe, R Benecke, K Domschke, S Seedat 41. Investigation of variants within antipsychotic candidate pharmacogenes associated with treatment outcome F Higgins, B Drogmoller, G Wright, L van der Merwe, N McGregor, B Chiliza, L Asmal, L Koen, D Niehaus, R Emsley, L Warnich 42. Effects of diet, smoking and alcohol consumption on disability (EDSS) in people diagnosed with multiple sclerosis S Janse van Rensburg, W Davis, D Geiger, F J Cronje, L Whati, M Kidd, M J Kotze 43. The clinical utility of neuroimaging in an acute adolescnet psychiatric inpatient population Z Khan, A Lachman, J Harvey 44. Relationships between childhood trauma (CT) and premorbid adjustment (PA) in a highly traumatised sample of patients with first-episode schizophrenia (FES) S Kilian, J Burns, S Seedat, L Asmal, B Chiliza, S du Plessis, R Olivier, R Emsley 45. Functional and cognitive outcomes using an mTOR inhibitor in an adolescent with TSC A Lachman, C van der Merwe, P Boyes, P de Vries 46. Perceptions about adolescent body image and eating behaviour K Laxton, A B R Janse van Rensburg 47. Clinical relevance of FTO rs9939609 as a determinant of cardio-metabolic risk in South African patients with major depressive disorder H K Luckhoff, M J Kotze 48. Childhood abuse and neglect as predictors of deficits in verbal auditory memory in non-clinical adolescents with low anxiety proneness L Martin, K Martin, S Seedat 49. The changes of pro-inflammatory cytokines in a prenatally stressed febrile seizure animal model and whether Rhus chirindensis may attenuate these changes A Mohamed, M V Mabandla, L Qulu 50. Influence of TMPRSS6 A736v and HFE C282y on serum iron parameters and age of onset in patients with multiple sclerosis K E Moremi, M J Kotze, H K Luckhoff, L R Fisher, M Kidd, R van Toorn, S Janse van Rensburg 51. Polypharmacy in pregnant women with serious mental illness E Thomas, E du Toit, L Koen, D Niehaus 52. Infant attachment and maternal depression as predictors of neurodevelopmental and behavioural outcomes at follow-up J Nothling, B Laughton, S Seedat 53. Differences in abuse, neglect and exposure to community violence in adolescents with and without PTSD J Nothling, S Suliman, L Martin, C Simmons, S Seedat 54. Assessment of oxidative stress markers in children with autistic spectrum disorders in Lagos, Nigeria Y Oshodi, O Ojewunmi, T A Oshodi, T Ijarogbe, O F Aina, J Okpuzor, O C F E A Lesi 55. Change in diagnosis and management of 'gender identity disorder' in pre-adolescent children S Pickstone-Taylor 56. Brain network connectivity in women exposed to intimate partner violence A Roos, J-P Fouche, B Vythilingum, D J Stein 57. Prolonged exposure treatment for PTSD in a Third-World, task-shifting, community-based environment J Rossouw, E Yadin, I Mbanga, T Jacobs, W Rossouw, D Alexander, S Seedat 58. Contrasting effects of early0life stress on mitochondrial energy-related proteins in striatum and hippocampus of a rat model of attention-deficit/ hyperactivity disorder V Russell, J Dimatelis, J Womersley, T-L Sterley 59. Attention-deficit hyperactivity disorder in adults: A South African perspective R Schoeman, M de Klerk, M Kidd 60. Cognitive function in women with HIV infection and early-life stress G Spies, C Fennema-Notestine, M Cherner, S Seedat 61. Changes in functional connectivity networks in bipolar disorder patients after mindfulness-based cognitic therapy J A Starke, C F Beckmann, N Horn 62. Post-traumatic stress disorder, overweight and obesity: A systematic review and meta-analysis S Suliman, L Anthonissen, J Carr, S du Plessis, R Emsley, S M J Hemmings, C Lochner, N McGregor L van den Heuvel, S Seedat 63. The brain and behaviour in a third-trimester equivalent animal model of fetal alcohol spectrum disorders P C Swart, C B Currin, J J Dimatelis, V A Russell 64. Irritability Assessment Model (IAM) to monitor irritability in child and adolescent psychiatric disorders. D van der Westhuizen 65. Outcome of parent-adolescent training in chilhood victimisation: Adaptive functioning, psychosocial and physiological variables D van der Westhuizen 66. The effect of ketamine in the Wistar-Kyoto and Sprague Dawley rat models of depression P J van Zyl, J J Dimatelis, V A Russell 67. Investigating COMT variants in anxiety sensitivity in South African adolescents L J Zass, L Martin, S Seedat, S M J Hemmings